Investment Analysts’ Updated EPS Estimates for October 19th (ACAD, ADAG, AMP, AMZN, AV, BBY, BCAX, BWAY, CBIO, CGEM)

Investment Analysts’ updated eps estimates for Monday, October 19th:

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $35.00 target price on the stock.

Adagene (NASDAQ:ADAG) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $7.00 target price on the stock.

Ameriprise Financial (NYSE:AMP) had its underperform rating reissued by analysts at Bank of America Corporation. They currently have a $445.00 target price on the stock, down from their previous target price of $570.00.

Yorkville Ives started coverage on shares of Amazon.com (NASDAQ:AMZN). Yorkville Ives issued an outperform rating and a $300.00 price target on the stock.

Aviva (LON:AV) had its buy rating reaffirmed by analysts at Berenberg Bank. They currently have a GBX 820 target price on the stock.

Balfour Beatty (LON:BBY) had its buy rating reissued by analysts at Berenberg Bank. The firm currently has a GBX 1,070 price target on the stock.

Bicara Therapeutics (NASDAQ:BCAX) had its buy rating reissued by analysts at BTIG Research. The firm currently has a $39.00 target price on the stock.

Brainsway (NASDAQ:BWAY) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $19.00 price target on the stock.

Crescent Biopharma (NASDAQ:CBIO) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $36.00 target price on the stock.

Cullinan Therapeutics (NASDAQ:CGEM) had its buy rating reaffirmed by analysts at BTIG Research. The firm currently has a $40.00 target price on the stock.

Clene (NASDAQ:CLNN) had its buy rating reiterated by analysts at HC Wainwright.

Comcast (NASDAQ:CMCSA) had its buy rating reaffirmed by analysts at Rosenblatt Securities. The firm currently has a $31.00 target price on the stock.

CorMedix (NASDAQ:CRMD) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $15.00 target price on the stock.

Cytokinetics (NASDAQ:CYTK) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $140.00 target price on the stock.

HC Wainwright assumed coverage on shares of Hadron Energy (NASDAQ:HDRN). They issued a buy rating on the stock.

HIVE Digital Technologies (NASDAQ:HIVE) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $10.00 target price on the stock.

Harmony Biosciences (NASDAQ:HRMY) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $50.00 target price on the stock.

IG Group (LON:IGG) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. They currently have a GBX 1,200 target price on the stock.

Imperial Brands (LON:IMB) had its hold rating reissued by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 2,700 price target on the stock.

Kistos (LON:KIST) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 420 target price on the stock.

Live Nation Entertainment (NYSE:LYV) had its buy rating reaffirmed by analysts at BTIG Research. They currently have a $215.00 price target on the stock.

Veradermics (NYSE:MANE) had its overweight rating reissued by analysts at Cantor Fitzgerald.

MDxHealth (NASDAQ:MDXH) had its neutral rating reiterated by analysts at BTIG Research.

Chardan Capital began coverage on shares of MannKind (NASDAQ:MNKD). The firm issued a buy rating and a $10.00 price target on the stock.

Newmark Group (NASDAQ:NMRK) had its neutral rating reiterated by analysts at Piper Sandler. The firm currently has a $13.00 target price on the stock, down from their previous target price of $14.00.

BTIG Research began coverage on shares of Newcleo (NASDAQ:NWCL). They issued a neutral rating on the stock.

Ocular Therapeutix (NASDAQ:OCUL) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $18.00 target price on the stock.

Oruka Therapeutics (NASDAQ:ORKA) had its buy rating reissued by analysts at BTIG Research. They currently have a $151.00 price target on the stock.

Pool (NASDAQ:POOL) had its neutral rating reiterated by analysts at Longbow Research.

Canaccord Genuity Group Inc. initiated coverage on shares of Quoin Pharmaceuticals (NASDAQ:QNRX). Canaccord Genuity Group Inc. issued a buy rating and a $18.00 price target on the stock.

Quantum Computing (NASDAQ:QUBT) had its buy rating reiterated by analysts at Rosenblatt Securities. They currently have a $22.00 target price on the stock.

Citizens Jmp initiated coverage on shares of Resideo Technologies (NYSE:REZI). They issued a market outperform rating and a $22.00 target price on the stock.

Rigel Pharmaceuticals (NASDAQ:RIGL) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $85.00 target price on the stock.

Recursion Pharmaceuticals (NASDAQ:RXRX) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $8.00 target price on the stock.

Savannah Resources (LON:SAV) had its speculative buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 11 price target on the stock.

Sol-Gel Technologies (NASDAQ:SLGL) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $110.00 target price on the stock.

Spyre Therapeutics (NASDAQ:SYRE) had its buy rating reaffirmed by analysts at BTIG Research. BTIG Research currently has a $121.00 price target on the stock.

Urogen Pharma (NASDAQ:URGN) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $75.00 target price on the stock.

Uranium Royalty (NASDAQ:UROY) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $4.50 target price on the stock.

Volex (LON:VLX) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 710 target price on the stock.

Volex (LON:VLX) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. They currently have a GBX 750 target price on the stock.

Varonis Systems (NASDAQ:VRNS) had its equal weight rating reiterated by analysts at Barclays PLC. They currently have a $50.00 price target on the stock.

Whirlpool (NYSE:WHR) had its neutral rating reissued by analysts at Longbow Research.

Zentalis Pharmaceuticals (NASDAQ:ZNTL) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $10.00 price target on the stock.